Henry Kaplan
Medical Oncology · Seattle, WANPI 1538243258
Payments from drug & device makers
What this record shows
That places this record below the midpoint for medical oncology clinicians in WA, where the typical reported total is $2,355.
Across 2 payments — averaging $13.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coherus Oncology, Inc.$15
- Gilead$12
Across 106 payments — averaging $32,778 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2.7M
- Seagen Inc.$626K
- Medivation LLC.$61K
- Merck$59K
- AbbVie$23K
What the payments were for
- Food & beverage$1556%
- Education$1244%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coherus Oncology, Inc. | 1 | $15 |
| Gilead | 1 | $12 |
How this compares
$27 in reported general payments places this provider in the 10th percentile of 162 medical oncology providers in Washington.
Other medical oncology in Seattle
- Bart ScottSeattle$1.3M
- Petros GrivasSeattle$628K
- Vijayakrishna GadiSeattle$573K
- Evan YuSeattle$296K
- Siddhartha DevarakondaSeattle$215K
- David MaloneySeattle$150K
- Gary LymanSeattle$130K
- Rafic FarahSeattle$114K
- Laura ChowSeattle$114K
- Shailender BhatiaSeattle$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.